SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144/A - Report of proposed sale of securities: [Amend]
SEC Accession No. 0001971857-23-000126
Filing Date
2023-05-16
Accepted
2023-05-16 09:54:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144/A  
1 primary_doc.xml 144/A 3930
  Complete submission text file 0001971857-23-000126.txt   5282
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144/A | Act: 33 | File No.: 001-38410 | Film No.: 23925825
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address
Rodriguez Javier (Reporting) CIK: 0001847919 (see all company filings)

Type: 144/A